Evelo Biosciences Inc. is a clinical-stage biotechnology company that pioneers the development of orally delivered therapies for the treatment of inflammatory diseases. With a focus on the gut-body network, their innovative approach aims to leverage natural immunology to restore balance in the immune system.
Notification